Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.4830
-0.0143 (-2.88%)
At close: Apr 25, 2025, 4:00 PM
0.4900
+0.0070 (1.45%)
Pre-market: Apr 28, 2025, 6:19 AM EDT
Calidi Biotherapeutics Stock Forecast
CLDI's stock price has decreased by -69.7% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Calidi Biotherapeutics stock have an average target of 15, with a low estimate of 10 and a high estimate of 20. The average target predicts an increase of 3,005.59% from the current stock price of 0.48.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 27, 2024.
Analyst Ratings
The average analyst rating for Calidi Biotherapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +1,970.39% | Jun 27, 2024 |
| Baird | Baird | Buy Maintains $45 → $20 | Buy | Maintains | $45 → $20 | +4,040.79% | May 15, 2024 |
| Baird | Baird | Buy Maintains $90 → $45 | Buy | Maintains | $90 → $45 | +9,216.77% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $110 → $20 | Strong Buy | Maintains | $110 → $20 | +4,040.79% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +22,674.33% | Nov 22, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.57
from -2.97
EPS Next Year
-0.34
from -0.57
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | n/a | n/a | n/a | |
| Avg | n/a | n/a | n/a | |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.48 | -0.34 | -0.30 |
| Avg | -0.57 | -0.34 | -0.30 |
| Low | -0.66 | -0.33 | -0.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.